Congfan Bu, Xinchang Zheng, Jialin Mai, Zhi Nie, Jingyao Zeng, Qiheng Qian, Tianyi Xu, Yanling Sun, Yiming Bao, Jingfa Xiao
Cancer cell lines are essential in cancer research, yet accurate authentication of these cell lines can be challenging, particularly for consanguineous cell lines with close genetic similarities. We introduce a new Cancer Cell Line Hunter (CCLHunter) method to tackle this challenge. This approach utilizes the information of single nucleotide polymorphisms, expression profiles, and kindred topology to authenticate 1389 human cancer cell lines accurately. CCLHunter can precisely and efficiently authenticate cell lines from consanguineous lineages and those derived from other tissues of the same individual. Our evaluation results indicate that CCLHunter has a complete accuracy rate of 93.27%, with an accuracy of 89.28% even for consanguineous cell lines, outperforming existing methods. Additionally, we provide convenient access to CCLHunter through standalone software and a web server at https://ngdc.cncb.ac.cn/cclhunter.
Cancer Res. 2021 May 15;81(10):2588-2599
[PMID:
33731442]
Nat Biotechnol. 2011 Jul 11;29(7):572-3
[PMID:
21747377]
An Acad Bras Cienc. 2019 Oct 14;91(3):e20180487
[PMID:
31618408]
Cancer Res. 2014 May 1;74(9):2377-84
[PMID:
24717177]
F1000Res. 2022 Apr 13;11:420
[PMID:
35949917]
Nucleic Acids Res. 1999 Jan 15;27(2):573-80
[PMID:
9862982]
Nat Rev Cancer. 2010 Jun;10(6):441-8
[PMID:
20448633]
Nature. 2009 Feb 19;457(7232):935-6
[PMID:
19225471]
Bioinformatics. 2013 Jan 1;29(1):15-21
[PMID:
23104886]
J Virol. 2014 Sep;88(18):10696-704
[PMID:
24991015]
Leukemia. 2003 Feb;17(2):416-26
[PMID:
12592342]
Cancer Res. 2012 Jul 15;72(14):3499-511
[PMID:
22802077]
J Natl Cancer Inst. 2013 Apr 3;105(7):452-8
[PMID:
23434901]
Int J Cancer. 2010 Jul 1;127(1):1-8
[PMID:
20143388]
PLoS One. 2017 Oct 12;12(10):e0186281
[PMID:
29023500]
Nature. 2019 May;569(7757):503-508
[PMID:
31068700]
Brief Bioinform. 2021 May 20;22(3):
[PMID:
32510568]
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
[PMID:
30371878]
Bioinformatics. 2014 Apr 1;30(7):923-30
[PMID:
24227677]
Cancers (Basel). 2019 Oct 15;11(10):
[PMID:
31618962]
BMC Genomics. 2019 Feb 4;20(Suppl 1):81
[PMID:
30712511]
J Biomol Tech. 2018 Jul;29(2):25-38
[PMID:
29805321]
Bioinformatics. 2014 Feb 01;30(3):301-4
[PMID:
24319002]
Front Oncol. 2022 Feb 11;12:800028
[PMID:
35223480]
Nat Biotechnol. 2015 Mar;33(3):306-12
[PMID:
25485619]
PLoS One. 2017 Feb 13;12(2):e0171435
[PMID:
28192450]
Leg Med (Tokyo). 2018 Jan;30:38-41
[PMID:
29154002]
Oncoimmunology. 2014 Aug 03;3(8):e954893
[PMID:
25960936]
Bioinformatics. 2010 Jan 1;26(1):139-40
[PMID:
19910308]
Nat Rev Cancer. 2010 Apr;10(4):241-53
[PMID:
20300105]
Nat Commun. 2021 Feb 22;12(1):1226
[PMID:
33619257]
ALTEX. 2005;22(2):103-9
[PMID:
15953965]
Am J Hum Genet. 2008 Jul;83(1):132-5; author reply 135-9
[PMID:
18606306]
BMC Genomics. 2009 Jun 23;10:277
[PMID:
19549304]
Nucleic Acids Res. 2011 Jan;39(Database issue):D38-51
[PMID:
21097890]
Genome Res. 2012 Mar;22(3):568-76
[PMID:
22300766]
Bioinformatics. 2009 Aug 15;25(16):2078-9
[PMID:
19505943]